You are here

Article info

Article menu
Download PDFPDF
Cancer genetics
Original article
Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases

Authors

  • Robert D Morgan Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • George J Burghel Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Nicola Flaum Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Michael Bulman Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Andrew R Clamp Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Jurjees Hasan Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Claire L Mitchell Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Helene Schlecht Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Emma R Woodward Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Fiona I Lallo Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Emma J Crosbie Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK Department of Obstetrics and Gynaecology, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Richard J Edmondson Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK Department of Obstetrics and Gynaecology, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Andrew J Wallace Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Gordon C Jayson Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • D Gareth R Evans Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor D Gareth R Evans, Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK; gareth.evans{at}mft.nhs.uk
View Full Text

Citation

Morgan RD, Burghel GJ, Flaum N, et al
Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases
Journal of Medical Genetics 2019;56:301-307.

Publication history

  • Received October 10, 2018
  • Revised December 14, 2018
  • Accepted January 5, 2019
  • First published January 25, 2019.
Online issue publication 
April 25, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.